| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Genitourinary Imaging |
1 Department of Radiology, University of California, San Francisco, 505
Parnassus Ave., San Francisco, CA 94143-0628.
2 Present address: Department of Radiology, University of Utah, 30 N 1900 East,
#1A71, Salt Lake City, UT 84132-2140.
3 Department of Urology, University of California, San Francisco, San Francisco,
CA 94143-0628.
OBJECTIVE. Our aim was to determine the effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging findings in patients with organ-confined prostate cancer.
MATERIALS AND METHODS. Endorectal MRI and MR spectroscopic imaging were performed in 43 patients with biopsy-proven prostate cancer before radical prostatectomy confirming organ-confined disease. For each sextant, two independent reviewers scored the degree of hemorrhage on a scale from 1 to 5 and recorded the presence or absence of capsular irregularity. A spectroscopist recorded the number of spectrally degraded voxels in the peripheral zone. The outcome variables of capsular irregularity and spectral degradation were correlated with the predictor variables of time from biopsy and degree of hemorrhage after biopsy.
RESULTS. Capsular irregularity was unrelated to time from biopsy or to degree of hemorrhage. Spectral degradation was inversely related to time from biopsy (p < 0.01); the mean percentage of degraded peripheral zone voxels was 18.5% within 8 weeks of biopsy compared with 7% after 8 weeks. Spectral degradation was unrelated to the degree of hemorrhage.
CONCLUSION. In organ-confined prostate cancer, capsular irregularity can be seen at any time after biopsy and is independent of the degree of hemorrhage, whereas spectral degradation is seen predominantly in the first 8 weeks after biopsy. MRI staging criteria and guidelines for scheduling studies after biopsy may require appropriate modification.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Turkbey, P. S. Albert, K. Kurdziel, and P. L. Choyke Imaging Localized Prostate Cancer: Current Approaches and New Developments Am. J. Roentgenol., June 1, 2009; 192(6): 1471 - 1480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shukla-Dave, H. Hricak, N. Ishill, C. S. Moskowitz, M. Drobnjak, V. E. Reuter, K. L. Zakian, P. T. Scardino, and C. Cordon-Cardo Prediction of Prostate Cancer Recurrence Using Magnetic Resonance Imaging and Molecular Profiles Clin. Cancer Res., June 1, 2009; 15(11): 3842 - 3849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Shukla-Dave, H. Hricak, N. M. Ishill, C. S. Moskowitz, M. Drobnjak, V. E. Reuter, K. L. Zakian, P. T. Scardino, and C. Cordon-Cardo Correlation of MR Imaging and MR Spectroscopic Imaging Findings with Ki-67, Phospho-Akt, and Androgen Receptor Expression in Prostate Cancer Radiology, March 1, 2009; 250(3): 803 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tamada, T. Sone, Y. Jo, A. Yamamoto, T. Yamashita, N. Egashira, S. Imai, and M. Fukunaga Prostate Cancer: Relationships between Postbiopsy Hemorrhage and Tumor Detectability at MR Diagnosis Radiology, August 1, 2008; 248(2): 531 - 539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hricak, P. L. Choyke, S. C. Eberhardt, S. A. Leibel, and P. T. Scardino Imaging Prostate Cancer: A Multidisciplinary Perspective Radiology, April 1, 2007; 243(1): 28 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. J. Choi, J. K. Kim, N. Kim, K. W. Kim, E. K. Choi, and K.-S. Cho Functional MR Imaging of Prostate Cancer RadioGraphics, January 1, 2007; 27(1): 63 - 75. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Futterer, S. W. T. P. J. Heijmink, T. W. J. Scheenen, J. Veltman, H. J. Huisman, P. Vos, C. A. H.-V. de Kaa, J. A. Witjes, P. F. M. Krabbe, A. Heerschap, et al. Prostate Cancer Localization with Dynamic Contrast-enhanced MR Imaging and Proton MR Spectroscopic Imaging Radiology, November 1, 2006; 241(2): 449 - 458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G S Payne and M O Leach Applications of magnetic resonance spectroscopy in radiotherapy treatment planning Br. J. Radiol., September 1, 2006; 79(Special_Issue_1): S16 - S26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Wang, H. Hricak, M. W. Kattan, H.-N. Chen, P. T. Scardino, and K. Kuroiwa Prediction of Organ-confined Prostate Cancer: Incremental Value of MR Imaging and MR Spectroscopic Imaging to Staging Nomograms Radiology, December 12, 2005; (2005) 2382041905. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
